Publications by the researcher in collaboration with JOSÉ TOMÁS RAMOS AMADOR (85)

2025

  1. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  2. Assessment of the steady-state drug-drug interactions between dolutegravir and ritonavir-boosted darunavir in adolescents

    AIDS

  3. Long-term non-progression in children with HIV: estimates from international cohort data

    AIDS, Vol. 39, Núm. 6, pp. 746-759

2024

  1. Experiencia de la cohorte nacional de mujeres embarazadas que viven con VIH y sus hijos en España: evolución de la transmisión materno-infantil de VIH e infecciones asociadas

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 101, Núm. 4, pp. 249-257

  2. Immunogenicity of the Conjugate Meningococcal ACWY-TT Vaccine in Children and Adolescents Living with HIV

    Microorganisms, Vol. 12, Núm. 1

2023

  1. Documento de consenso de la Sociedad Española de Infectología Pediátrica y el Comité Asesor de Vacunas de la Asociación Española de Pediatría para la vacunación en inmunodeprimidos

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 99, Núm. 6, pp. 403-421

  2. Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country

    European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 575-579

  3. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

  2. Integrase inhibitors in children and adolescents: Clinical use and resistance

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 10, pp. 2784-2792

  3. Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial

    Frontiers in Pediatrics, Vol. 10

  4. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand

    Antiviral Therapy, Vol. 27, Núm. 3

  5. Past and future of HIV infection. A document based on expert opinion

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 131-156

  6. Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain

    Journal of acquired immune deficiency syndromes (1999), Vol. 91, Núm. 4, pp. 373-380

  7. Prevalence of psychological symptoms and associated risk factors in a Spanish sample of HIV-positive youth compared to uninfected peers

    Anales de Pediatria, Vol. 96, Núm. 3, pp. 203-212

  8. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

  9. SARS-CoV-2 Infection in Children and Adolescents Living With HIV in Madrid

    The Pediatric infectious disease journal, Vol. 41, Núm. 10, pp. 824-826

  10. Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial

    Nutrients, Vol. 14, Núm. 5

  11. miRNA Profile Based on ART Delay in Vertically Infected HIV-1 Youths Is Associated With Inflammatory Biomarkers and Activation and Maturation Immune Levels

    Frontiers in Immunology, Vol. 13

2021

  1. Actividad cerebral en jóvenes infectados por el virus de la inmunodeficiencia humana por transmisión vertical: estudio piloto de resonancia magnética funcional

    Revista de neurologia, Vol. 72, Núm. 10, pp. 343-351